Dendreon: Targeting Cancer, Transforming Lives
 
Upcoming Event
Jan 15, 2009
11:00 AM PT 		J.P. Morgan 27th Annual Healthcare Conference
Listen to webcast
Reminder Remind me

Archived Events
Nov 18, 2008
8:55 AM ET 		Lazard Capital Markets 5th Annual Healthcare Conference
Listen to webcast
Nov 12, 2008
9:55 AM ET 		Rodman & Renshaw 10th Annual Healthcare Conference
Listen to webcast
Show Additional Information
Oct 6, 2008
9:00 AM ET 		Dendreon Conference Call - Interim Results of IMPACT Trial
Listen to webcast
Aug 12, 2008
4:30 PM ET 		Dendreon Corporation Second Quarter 2008 Financial Results
Listen to webcast
Mar 13, 2008
8:00 AM PT 		Dendreon Corporation Fourth Quarter 2007 Financial Results
Listen to webcast


Nicole Provost, Ph.D., vice president of product development, recently presented the results of potency testing for PROVENGE at the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee Meeting. The purpose of the committee meeting was to discuss Potency Measurement for Cell and Gene Therapy Products. The full presentation is available at the following links:
Slides
Meeting Transcript